HerWellReport Independent Women’s Health Research

Research

Curcumin for Menopause: Evidence, Interactions and Cautions

Curcumin is an ingredient used in menopause supplements marketed to women. Below is what it has actually been studied for, how strong that evidence is, the drug interactions and cautions on record, and the primary source our grade rests on — all drawn from the HerWellReport ingredient dataset.

HerWellReport Evidence Gradelimited
Studied forHot flushes, mood, bone density and metabolic markers in postmenopausal women; separately studied for osteoarthritis and non-alcoholic fatty liver disease
Used inMenopause supplements
Helps stress leaks?No
Helps hot flushes?Unclear

Also sold as: Turmeric extract; Curcuma longa; diferuloylmethane

What the evidence says about Curcumin

A systematic review of 12 RCTs in postmenopausal women, using 80-1,000 mg daily for 8 weeks to 12 months, found conflicting results on hot flushes: one trial reported significantly fewer than placebo and another found no association, with no significant effect on psychological or sexual outcomes and no change in serum oestradiol. Most trials were small, ten of the twelve came from a single country, and several combined curcumin with other agents, so the reviewers concluded the RCT results are conflicting and limited and called for well-designed placebo-controlled trials. Curcumin is not assessed in its own right in the Menopause Society's 2023 nonhormone therapy position statement; it appears once, inside the vitamin E discussion, as part of a trial of curcumin and vitamin E.

The grade "limited" means: limited — One or two small human trials, or trials for a closely related outcome. Grades are explained in full on our methodology page.

Read the primary source this grade rests on (opens in a new tab).

Curcumin drug interactions

No documented drug interactions in the sources we checked. That is not the same as proof of safety alongside your medication — it usually means the question has not been studied. Ask a pharmacist before combining it with prescription drugs.

Who should be careful with Curcumin

  • NIH LiverTox scores turmeric and curcumin A, a well documented cause of clinically apparent liver injury, usually 1 to 4 months after starting
  • high-bioavailability formulations using piperine (black pepper) or lipid nanoparticles are the ones most often implicated
  • the HLA-B*35:01 allele was found in over 70% of cases versus 10-15% of controls
  • stop and seek medical advice for jaundice, dark urine or unexplained fatigue
  • NCCIH says supplement doses may be unsafe in pregnancy

Read more on HerWellReport

This entry is generated from row "Curcumin" of the HerWellReport ingredient dataset (v2.1, updated 2026-09-23). The dataset is free to reuse under CC BY 4.0 — how to cite it. Ingredient evidence is not evidence for any finished product, and nothing here is medical advice.